Mid-Atlantic Bio

North Carolina Joins Mid-Atlantic Bio As Strategic Partner

Mar 08, 2012

Expands Footprint of Leading Regional Bioscience Conference Bethesda, MD — The Mid-Atlantic Bio conference today announced that the North Carolina Biotechnology Center has joined the Virginia Biotechnology Association (VABIO), Tech Council of Maryland (TCM), and Mid-Atlantic Venture Association (MAVA) as a 2012 strategic partner.  The addition of North Carolina to the Mid-Atlantic Bio geography solidifies [...] Read the full entry »

Baltimore-Based CSA Medical Raises $20.5 Million in Second Round

Feb 21, 2012

Baltimore-Based CSA Medical Raises $20.5 Million in Second Round Baltimore — CSA Medical, the Baltimore-based developer of a spray cryotherapy device that freeze and destroy unwanted tissue inside the body, said on Thursday it has raised $20.5 million in its second round of funding, co-led by Intersouth Partners and First Analysis. Other investors in the [...] Read the full entry »

Baltimore-Based CSA Medical Raises $12.6 Million in First Round

Feb 21, 2012

Baltimore-Based CSA Medical Raises $12.6 Million in First Round Baltimore — CSA Medical, a Baltimore-based developer of devices that flash freeze and treat diseased tissue inside the body, said on Tuesday it has raised $12.6 million in its first round of funding, which included a new investment from Blue Heron Capital. The company, which said [...] Read the full entry »

Blacksburg-Based Intrexon Raises $100 Million in Fifth Round

Feb 21, 2012

Blacksburg-Based Intrexon Raises $100 Million in Fifth Round Blacksburg, Va. — Intrexon, a Blacksburg-based life sciences firm developing technology to control the delivery and targeting of cancer drugs, said on Tuesday it has raised $100 million in its fifth round of funding, increasing its total backing to $259 million since 1998. The company said unnamed [...] Read the full entry »

Rockville-Based Supernus Raises $42 Million to Prepare Drugs for Launch

Feb 21, 2012

Rockville-Based Supernus Raises $42 Million to Prepare Drugs for Launch Rockville, Md. — Supernus Pharmaceuticals, a Rockville-based specialty pharmaceutical firm developing treatments for disorders of the central nervous system, said on Friday it has raised $42 million through a pair of transactions. The company said it generated $27 million from the sale of its TCD [...] Read the full entry »